Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Journal of Colorado.
Press releases published on April 3, 2025
Boundless Bio to Participate in the Needham Virtual Healthcare Conference
GlobeNewswire
·
April 3, 2025
SAN DIEGO, April 03, 2025 (GLOBE NEWSWIRE) -- Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene amplified …
Auron Presents New Preclinical Data for AUTX-703 in Small Cell Lung Cancer (SCLC)
GlobeNewswire
·
April 3, 2025
NEWTON, Mass., April 03, 2025 (GLOBE NEWSWIRE) -- Auron Therapeutics, a clinical-stage biotechnology company targeting cell-state plasticity to improve patient outcomes in oncology and inflammatory disease, today announced data from a poster presentation …
Axonius Appoints David Walters as Chief Revenue Officer
GlobeNewswire
·
April 3, 2025
NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- Axonius, the leader in cyber asset management that delivers visibility and actionability across all digital assets, today announced the appointment of David Walters as Chief Revenue Officer (CRO). Walters brings …
Lianhe Sowell International Group Ltd Announces Pricing of Initial Public Offering
GlobeNewswire
·
April 3, 2025
Shenzhen, China, April 03, 2025 (GLOBE NEWSWIRE) -- Lianhe Sowell International Group Ltd (the “Company”), a provider of machine vision products and solutions applied in a wide range of businesses across industries in China, today announced the pricing of …
Breaking News: Early Clinical Trial on Plant-Based Finasteride Alternative Shows Exciting Results Amid Growing Concerns Over Drug Side Effects
GlobeNewswire
·
April 3, 2025
CLEVELAND, April 03, 2025 (GLOBE NEWSWIRE) -- The hair loss industry is at a tipping point. A recent Wall Street Journal exposé has reignited concerns about the severe and long-term side effects of finasteride, the FDA-approved drug for male pattern …
Lane One Transport Automates Carrier Communication and Qualification with Integrated Parade and Descartes Solutions
GlobeNewswire
·
April 3, 2025
ATLANTA, April 03, 2025 (GLOBE NEWSWIRE) -- Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, announced that Texas-based Lane One Transport, a leader in freight brokerage, is …
Unlock the Future of Cybersecurity at the OpenSSL Conference 2025 in Prague
GlobeNewswire
·
April 3, 2025
NEWARK, Del., April 03, 2025 (GLOBE NEWSWIRE) -- The OpenSSL Corporation and the OpenSSL Foundation are proud to announce the OpenSSL Conference 2025, taking place from October 7 to 9, 2025, in Prague, Czech Republic, at the Vienna House by Wyndham …
Sai Life Sciences sets up Peptide Research Center in India
GlobeNewswire
·
April 3, 2025
HYDERABAD, India, April 03, 2025 (GLOBE NEWSWIRE) -- Sai Life Sciences Limited (BSE: 544306 I NSE: SAILIFE), an innovator-focused Contract Research, Development, and Manufacturing Organization (CRDMO), has inaugurated a dedicated Peptide Research Center at …
Solo.io Announces MCP Gateway to Simplify and Secure AI Agent Development in Kubernetes
GlobeNewswire
·
April 3, 2025
LONDON, April 03, 2025 (GLOBE NEWSWIRE) -- KubeCon + CloudNativeCon Europe 2025 -- Solo.io, the leading cloud native application networking company, today announced MCP Gateway, a Model Context Protocol (MCP) gateway for kgateway, the ecosystem’s most …
Arialief: We Tested It—Here’s Our Honest Arialief Review “Shocking Conclusion”
GlobeNewswire
·
April 3, 2025
AURORA, Colo., April 03, 2025 (GLOBE NEWSWIRE) -- Arialief caught my attention from the very first day I heard about it. It’s not every day I commit to testing a new supplement for over three months and then share my personal journey. As someone who has …
big xyt Announces Formal Bid for European Consolidated Tape Provider with Widespread Industry Support
GlobeNewswire
·
April 3, 2025
London, April 03, 2025 (GLOBE NEWSWIRE) -- big xyt, a leading independent provider of high-quality European trade data and analytics, today announced its formal intent to become the official provider of the EU Consolidated Tape (CT) for equities and ETFs. …
Boehringer Ingelheim strengthens antibody-drug conjugate portfolio with new NBE Therapeutics R&D center in Basel
GlobeNewswire
·
April 3, 2025
CHF 27 million investment significantly bolsters Boehringer's ADC portfolio, driven by its subsidiary, NBE Therapeutics, to achieve the company’s aim of transforming the lives of people with cancer. Basel, Switzerland, Thursday, 03.04.2025 – Today NBE …
LIfT BioSciences gains access to half a million allogeneic donors through collaboration with Gift of Life Biologics
GlobeNewswire
·
April 3, 2025
Press release LIfT BioSciences gains access to half a million allogeneic donors through collaboration with Gift of Life Biologics Access to extensive donor pool supports LIfT’s move into the clinic London, 03 April 2025 – LIfT BioSciences, (‘LIfT’ or ‘the …
Ti5ROBOT stellt auf der HANNOVER MESSE 2025 neue Humanoide vor
GlobeNewswire
·
April 3, 2025
HANNOVER, Deutschland, April 03, 2025 (GLOBE NEWSWIRE) -- Die weltberühmte HANNOVER MESSE 2025 findet vom 31. März bis 4. April 2025 statt. In Deutschland treffen sich die Top-Industriegiganten, darunter der aufstrebende chinesische Star Ti5ROBOT aus …
Press Release: Rilzabrutinib granted orphan drug designation in the US for two rare diseases with no approved medicines
GlobeNewswire
·
April 3, 2025
Rilzabrutinib granted orphan drug designation in the US for two rare diseases with no approved medicines Designation granted for warm autoimmune hemolytic anemia and IgG4-related disease Rilzabrutinib is currently under regulatory review in the US, EU and …
Communiqué de presse : Le rilzabrutinib obtient la désignation de médicament orphelin aux États-Unis pour le traitement de deux maladies rares contre lesquelles il n’existe aucun médicament approuvé
GlobeNewswire
·
April 3, 2025
Le rilzabrutinib obtient la désignation de médicament orphelin aux États-Unis pour le traitement de deux maladies rares contre lesquelles il n’existe aucun médicament approuvé Désignation accordée pour l’anémie hémolytique à anticorps chauds et la maladie …
Veteran Banker Joins Avextra’s Supervisory Board
GlobeNewswire
·
April 3, 2025
News Release Dr. Stefan Jentzsch, Partner at the global investment firm Perella Weinberg Partners has been appointed to Avextra’s Supervisory Board, bringing decades of experience in corporate finance, M…
FibroBiologics gibt wissenschaftlicher Fortschritte bei der Reparatur von Hirngewebe bekannt
GlobeNewswire
·
April 3, 2025
HOUSTON, April 03, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (im Folgenden kurz „FibroBiologics“), ein im klinischen Stadium tätiges Biotechnologieunternehmen mit über 240 erteilten und angemeldeten Patenten für die Entwicklung von …
FibroBiologics annonce des progrès scientifiques suite à la confirmation des résultats relatifs à la réparation de tissus cérébraux
GlobeNewswire
·
April 3, 2025
HOUSTON, 03 avr. 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq : FBLG), ou « FibroBiologics », une société de biotechnologie au stade clinique détenant plus de 240 brevets délivrés et en instance portant sur le développement de thérapies et de …